The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Researchers Explore HLA-B27’s Role in the Development of Spondylitis

Researchers Explore HLA-B27’s Role in the Development of Spondylitis

June 14, 2013 • By Will O’Brien, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A hallmark feature of ankylosing spondylitis (AS) and other spondylarthropathies is the involvement of the axial skeleton, leading to syndesmophyte formation and eventual fusion of the spine. This aggressive bone formation is paradoxically linked to profound osteoporosis, which makes these patients particularly vulnerable to fragility fracture. Interestingly, bone mineral density scores often improve following treatment with tumor necrosis factor (TNF)–blocking agents; however the role of TNF-α in bone remodeling is not fully understood in AS.

You Might Also Like
  • Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis
  • Letters: UCLA Study on HLA-B27 Link with Ankylosing Spondylitis at Forefront
  • How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

A study by Layh-Schmitt and colleagues, published in Arthritis & Rheumatism, reports the increased sensitivity of human-HLA-B27 transgenic rat bone marrow monocytes to TNF-α stimulation and osteoclast differentiation, compared to wild-type or human-HLA B7 transgenic rat controls.1 The increased expression and production of active interleukin (IL) 1α was found to drive this process, and blockade of IL-1α was sufficient to inhibit osteoclast development.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Based on results from their prior work, these researchers investigated the role of HLA-B27 in inducing endoplasmic reticulum (ER) stress and activating the unfolded protein response (UPR) in cultured monocytes. Interestingly, they found increased expression of binding immunoglobulin protein (BiP) and activated splice variants of x-box binding protein 1 (XBP1) after stimulation with TNF-α, with increased coprecipitation and localization of HLA-B27 and BiP, supporting their hypothesis of increased ER stress in this model.

Curiously, the HLA-B27 allele, known for its strong genetic association with AS, is reported to have a tendency to misfold or form homodimers. In experimental animal models, increased HLA-B27 expression and resultant misfolding has been implicated in ER stress and the activation of UPR. This work offers a novel insight into the role of HLA-B27 in support of an antigen-independent pathway resulting in the development of spondylitis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. O’Brien is a rheumatology fellow at Brigham and Women’s Hospital in Boston.

Reference

  1. Layh-Schmitt G, Yang EY, Kwon G, Colbert RA. HLA-B27 alters the response to TNFα and promotes osteoclastogenesis in bone marrow monocytes from HLA-B27 transgenic rats. Arthritis Rheum. 2013; May 10. [Epub ahead of print]

 

Filed Under: Conditions, Research Reviews, Spondyloarthritis Tagged With: Ankylosing Spondylitis, bone formation, HLA-B27, osteoclast, spondylarthropathy

You Might Also Like:
  • Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis
  • Letters: UCLA Study on HLA-B27 Link with Ankylosing Spondylitis at Forefront
  • How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis
  • Coverage Requirements for HLA-B27 Vary by Testing Methodology

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)